Emily Daykin

The University of Texas MD Anderson Cancer Center

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes”.

Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes

Molecular Genetics and Metabolism(2021)10.1016/j.ymgme.2021.01.002

N/A

0DataRank · unranked

80 citations

Emory Ryan, Ellen Sidransky, Emily Daykin

Current and emerging pharmacotherapy for Gaucher disease in pediatric populations

Expert Opinion on Pharmacotherapy(2021)10.1080/14656566.2021.1902989

N/A

0DataRank · unranked

29 citations

Emory Ryan, Emily Daykin, Ellen Sidransky, Richard Sam

Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3

Molecular Genetics and Metabolism(2021)10.1016/j.ymgme.2021.09.008

N/A

0DataRank · unranked

6 citations

Nicole Fleischer, Magy Abdelwahab, Nehal F. Hassib, Raphael Schiffmann, Emory Ryan +2 more

An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease

Journal of Genetic Counseling(2023)10.1002/jgc4.1677

N/A

0DataRank · unranked

2 citations

Chelsie N. Poffenberger, Jenny Do, Emory Ryan, Nahid Tayebi, Ellen Sidransky +3 more